Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
SAN FRANCISCO, March 9, 2021 /PRNewswire/ -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is investigating p
Acadia Pharmaceuticals stock leads premarket losers after FDA finds undisclosed 'deficiencies' in NDA
08:37am, Tuesday, 09'th Mar 2021
Shares of Acadia Pharmaceuticals Inc. plunged 42.1% to pace all premarket decliners Tuesday, in the wake of the company's announcement that the Food and Drug Administration found undisclosed deficienc
ACAD Stock Price Fell Over 40% Pre-Market: Why It Happened
08:22am, Tuesday, 09'th Mar 2021
The stock price of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) fell by over 40% pre-market. This is why it happened.
ACADIA Pharmaceuticals, Inc. (ACAD) Presents at Cowen Healthcare Broker Conference Call - (Transcript)
11:30pm, Monday, 01'st Mar 2021
ACADIA Pharmaceuticals, Inc. (ACAD) Presents at Cowen Healthcare Broker Conference Call - (Transcript)
ACADIA (ACAD) Beats on Q4 Earnings, Misses on Revenues
10:39am, Thursday, 25'th Feb 2021
ACADIA's (ACAD) loss narrows in the fourth quarter of 2020 while it misses estimates for revenues. Nuplazid drives year-over-year revenues.
ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q4 2020 Results - Earnings Call Transcript
07:27pm, Wednesday, 24'th Feb 2021
ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q4 2020 Results - Earnings Call Transcript
Acadia Pharmaceuticals (ACAD) Reports Q4 Loss, Lags Revenue Estimates
06:12pm, Wednesday, 24'th Feb 2021
Acadia (ACAD) delivered earnings and revenue surprises of 12.50% and -1.52%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
A Preview Of ACADIA Pharmaceuticals's Earnings
10:11am, Tuesday, 23'rd Feb 2021
On Wednesday, February 24, ACADIA Pharmaceuticals (NASDAQ:ACAD) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for
01:42pm, Wednesday, 17'th Feb 2021
Acadia (ACAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
09:00am, Wednesday, 10'th Feb 2021
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2020 financial results on Wednesday, February 24, 2021, after th
Acadia: Waxing And Waning Into A Big PDUFA
06:19am, Tuesday, 02'nd Feb 2021
After a nice close to 2020, Acadia's shares hit a slick spot in 2021.When they are waxing, as they so often do, Acadia's shares are good candidates for selling covered calls.
Acadia Pharmaceuticals Announces Commercial Leadership Change
04:05pm, Wednesday, 27'th Jan 2021
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Michael Yang, Executive Vice President and Chief Commercial Officer, will be leaving the organization effect
ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual J.P. Morgan Healthcare Conference (Transcript)
05:19pm, Tuesday, 12'th Jan 2021
ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual J.P. Morgan Healthcare Conference (Transcript)
5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential
08:15am, Monday, 21'st Dec 2020
After an incredibly wild and wooly year for investors, many across Wall Street are cautiously optimistic for 2021.
Raymond James Top Health Care Picks Crushing S&P 500: 4 Stocks to Buy Now
07:59am, Thursday, 03'rd Dec 2020
The health care sector as a whole has been a top performer this year, and there is every reason to believe that strong performance will carry through to 2021.
